Concepedia

BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

Peter Iversen, C. Tyrrell, Amir V. Kaisary, John Anderson, Hendrik Van Poppel, Teuvo L.J. Tammela, M. C. Chamberlain, Kevin Carroll, I. Melezínek

The Journal of Urology · 2000 · 345 citations · 16 references

DOI

Abstract

Monotherapy with 150 mg. bicalutamide is an attractive alternative to castration in patients with locally advanced prostate cancer for whom immediate hormone therapy is indicated.

References

16

Cancer statistics, 1999

Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1999 · 3.1K citations · Full text

PROGRESSIVE OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER

Stephen Dunn, David W. Ferguson, GREGORY LOMAS et al. · The Journal of Urology · 2000 · 453 citations

A Randomised Comparison of ‘Casodex’<sup>TM</sup> (Bicalutamide) 150 mg Monotherapy versus Castration in the Treatment of Metastatic and Locally Advanced Prostate Cancer

CJ Tyrrell, Amir Kaisary, Peter Iversen et al. · European Urology · 1998 · 307 citations

, , +8

Patients' choice of treatment in stage D prostate cancer

Barrie R. Cassileth, E. James Seidmon, Mark S. Soloway et al. · Urology · 1989 · 206 citations

, , +3

Testosterone Deficiency As a Risk Factor for Hip Fractures in Men: A Case-Control Study

Jeffrey A. Jackson, Mark W. Riggs, A. Michael Spiekerman · The American Journal of the Medical Sciences · 1992 · 188 citations

, , +7